Docosahexaenoic Acid Serving As Sensitizing Agents And Gefitinib Resistance Revertants In EGFR Targeting Treatment

OBJECTIVE: Due to the resistance of cancer cells, chemotherapy has been severely restricted. Docosahexaenoic acid (DHA) has been broadly identified as the chemo-sensitizing agent and revertant of multidrug resistance owing to its pleiotropic characteristics; however, it has not been well interpreted...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xuansheng, Ge, Lei, Yan, Aiwen, Ding, Yuyin, Tao, Junye, Liu, Qianqian, Qiao, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897069/
https://www.ncbi.nlm.nih.gov/pubmed/31819534
http://dx.doi.org/10.2147/OTT.S225918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897069/
https://www.ncbi.nlm.nih.gov/pubmed/31819534
http://dx.doi.org/10.2147/OTT.S225918

Ejemplares similares